Is Brexit Good for Biotech? Maybe

As the aftershocks from Brexit continue to batter global stock markets, and the Dow down triple digits , RBC analyst Michael Yee makes an argument that Brexit could be good for biotech stocks.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.